Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia

PHASE4RecruitingINTERVENTIONAL

Enrollment

112

Participants

Timeline

Start Date

November 6, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

August 31, 2024

Conditions

Dyslipidemia

Interventions

DRUG

Rosuvastatin Immediate-Release Tablet (IRT) 10mg

DRUG

Rosuvastatin orally disintegrating tablet (SUVARO®ODT) 10mg

Trial Locations (1)

RECRUITING

Division of Cardiology, Department of Internal Medicine, Yonsei Univerisity,, Seoul

All Listed Sponsors

lead

Yonsei University

OTHER